Pre-Market Selling Illusion, page-7

I'm hoping riskiketkar
I suspect the research will eventually provide the FDA enough comfort... the real test is doctor prescription behaviour and if consumers continue to demand! Prior to the FDA issue, the US market was unsustainable. The market was being driven by consumer advertising and demand from patients with questionable symptoms, so it’s not surprising to see it cool off in response.
Will it return? these issues are never clear cut in terms of consumer and doctor response - perception is reality and once the question mark is raised about the risk of the product it can be hard to change it... i don't think people[men] who truly are testosterone deficient would stop[ taking it in response, but those on the margin / with questionable symptoms may or may not return…